Citation counts can be found on my Google Scholar Page

Aberrant levels of cortical myelin distinguish individuals with depressive disorders from healthy controls. Baranger DAA, Halchenko YO, Satz S, Ragozzino R, Iyengar S, Swartz HA, Manelis A. Neuroimage: Clinical (2021) 32, 102790. doi: 10.1016/j.nicl.2021.102790.

Polygenic risk scores for commonly used substances predict brain structural differences in drug naïve children. Hatoum AS, Johnson EC, Baranger DAA, Paul SE, Agrawal A, Bogdan R. Genes, Brain, and Behavior (2021) doi: 10.1111/gbb.12756.

Psychotic-like experiences and polygenic liability in the ABCD Study. Karcher NR, Paul SE, Johnson EC, Hatoum AS, Baranger DAA, Thompson WK, Barch DM, Bogdan R. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2021) doi: 10.1016/j.bpsc.2021.06.012.

Same data, different conclusions: Radical dispersion in empirical results when independent analysts operationalize and test the same hypothesis. Schweinsberg M, Feldman M, Staub N [et al. including Baranger DAA]. Organizational Behavior and Human Decision Processes (2021) 165(1) 228-249. doi: 10.1016/j.obhdp.2021.02.003.

The longitudinal stability of fMRI activation during reward processing in adolescents and young adults. Baranger DAA, Lindenmuth M, Nance M, Guyer A, Keenan K, Hipwell AE, Shaw DS, Forbes EE. Neuroimage (2021) 232, 117872. doi: 10.1016/j.neuroimage.2021.117872

Neuroticism and Reward-related Ventral Striatum Activity: Probing Vulnerability to Stress-Related Depression. Bondy E, Baranger DAA, Balbona J, Sputo K, Paul SE, Olmanns T, Bogdan R. Journal of Abnormal Psychology (2021) 130(3), 223–235. doi: 10.1037/abn0000618.

Genome-wide association study meta-analysis of cannabis use disorder in over 380,000 individuals reveals distinct genetic architectures of cannabis use and use disorder. Johnson EC, Demontis D, Thorgeirsson TE, [et al. including Baranger DAA]. The Lancet Psychiatry (2020) 7(12) 1032-1045. doi: 10.1016/S2215-0366(20)30339-4.

Borderline personality disorder traits are not associated with brain structure in two large independent samples. Baranger DAA, Few LR, Sheinbein D, Agrawal A, Oltmanns TF, Knodt AR, Barch DM, Hariri AR, Bogdan R. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 5(7): 669-677. doi: 10.1016/j.bpsc.2020.02.006.

Convergent evidence for predispositonal effects of brain volume on alcohol consumption. Baranger DAA, Demers CH, Elsayed NM, Knodt AR, Radtke SR, Desmarais A, Few LR, Agrawal A, Heath AC, Barch DM, Squeglia LM, Williamson DE, Hariri AR, Bogdan R. Biological Psychiatry (2020) 87(7):645-655. doi: 10.1016/j.biopsych.2019.08.029

Editorial: Causal, Predispositional, or Correlate? Group Differences in Cognitive Control-Related Brain Function in Cannabis-Using Youth Raise New Questions. Baranger DAA, Bogdan R. JAACAP. (2019) 58(7):665-667 doi: 10.1016/j.jaac.2019.05.018

Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use. Karcher NR, Barch DM, Demers CH, Baranger DAA, Heath AC, Lynskey MT, Agrawal A. JAMA Psychiatry, (2019) 76(1):87-94. doi:10.1001/jamapsychiatry.2018.2546

Polygenic risk scores in clinical psychology: Bridging genomic risk to individual differences. Bogdan R, Baranger DAA, Agrawal A. (2018) Annual Review of Clinical Psychology, (2018) 14; doi: 10.1146/annurev-clinpsy-050817-084847

Metabotropic glutamate receptor 2/3 (mGluR2/3) activation suppresses TRPV1 sensitization in mouse, but not human sensory neurons. Sheahan T, Valtcheva M, McIlvried L, Pullen M, Baranger DAA, Gereau IV R. eNeuro (2018) 0412-17.2018; doi: 10.1523/ENEURO.0412-17.2018

Genomewide association study identifies novel locus for cannabis dependence. Agrawal A, Chou Y, Carey C, Baranger DAA, Zhang B, Sherva R, Wetherill L, Lynskey MT, Bierut L, Degenhardt L, Farrer L, Gelernter J, Hariri AR, Heath A, Kranzler H, Madden PAF, Martin NG, Montgomery G, Porjesz B, Wang T, Edenberg HJ, Foroud T, Goate AM, Bogdan R, Nelson E.   Molecular Psychiatry, (2017). doi: 10.1038/mp.2017.200

Perceived stress is associated with increased rostral middle frontal gyrus cortical thickness: A family-based and discordant sibling investigation. Michalski LJ, Demers CH, Baranger DAA, Barch DM, Harms MP, Burgess G, Bogdan R. Genes, Brain, and Behavior, (2017) 16(8), 781-789. doi:10.1111/gbb.12404

Evidence for Diurnal Variation of Threat-related Amygdala Reactivity. Baranger DAA, Margolis S, Hariri AR, Bogdan R. Social, Cognitive, and Affective Neuroscience, (2017) 12(8), 1272-1283. doi:10.1093/scan/nsx057

PER1 rs3027172 Genotype Interacts with Early Life Stress to Predict Problematic Alcohol Use, but Not Reward-Related Ventral Striatum Activity. Baranger DAA, Ifrah C, Prather AA, Carey CE, Corral- Frías NS, Conley ED, Hariri AR, Bogdan R. Frontiers in Psychology, (2016) 7(3), 1–10. doi:10.3389/fpsyg.2016.00464

Genetic moderation of stress effects on the corticolimbic circuit. Bogdan R, Pagliaccio D, Baranger DAA, Hariri AR. Neuropsychopharmacology (2015) 41(7), 275–296. doi:10.1038/npp.2015.216

Decomposition of brain diffusion imaging data uncovers latent schizophrenias with distinct patterns of white matter anisotropy. Arnedo J, Mamah D, Baranger DAA, Harms MP, Barch DM, Svrakic D, de Erausquin GA, Cloninger CR​. Neuroimage (2015) 120, 43-54. doi:10.1016/j.neuroimage.2015.06.083

Stress-related anhedonia is associated with reward-related ventral striatum reactivity and transdiagnostic psychiatric symptomatology. Corral-Frías NS, Nikolova YS, Michalski L, Baranger DAA, Hariri AR, Bogdan R. Psychological Medicine (2015) 45(12), 2605–17. doi:10.1017/S0033291715000525

DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity. Callicott JH, Feighery EL, Mattay VS, White MG, Chen Q, Baranger DAA, Berman KF, Lu B, Hongjun S, Ming G, Weinberger DR. Journal of Clinical Investigation (2013) 123(7), 2961-2964. doi:10.1172/JCI67510

Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation. Addicott MA, Baranger DAA, Kozink RV, Smoski MJ, Dichter GS, McClernon JF. Psychopharmacology (2012) 219(2), 563–573. doi:10.1007/s00213-011-2404-3